CIK: 0001974915 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $2,941,274 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QQQ | Invesco QQQ Trust Series 1 | 350,000 | $215,009 | 7.3% | — | — | PUT | 46090E103 |
| TERN | Terns Pharmaceuticals Inc | 4,500,000 | $181,800 | 6.2% | $23.11 | 0.0% | COM | 880881107 |
| MRK | Merck & Co Inc | 775,000 | $81,577 | 2.8% | $93.24 | 0.0% | COM | 58933Y105 |
| ARWR | Arrowhead Pharmaceuticals Inc | 900,000 | $59,751 | 2.0% | $49.01 | 0.0% | COM | 04280A100 |
| OLMA | Olema Pharmaceuticals Inc | 1,650,000 | $41,250 | 1.4% | $17.79 | 0.0% | COM | 68062P106 |
| IMCR | Immunocore Holdings PLC | 585,000 | $20,305 | 0.7% | $34.71 | — | ADS | 45258D105 |
| UPB | Upstream Bio Inc | 720,000 | $19,548 | 0.7% | $24.89 | 0.0% | COM | 91678A107 |
| CBIO | Crescent Biopharma Inc | 1,500,000 | $17,790 | 0.6% | $12.74 | 0.0% | COM | G2545C104 |
| BCRX | BioCryst Pharmaceuticals Inc | 2,250,000 | $17,550 | 0.6% | $7.23 | 0.0% | COM | 09058V103 |
| PEN | Penumbra Inc | 50,000 | $15,546 | 0.5% | $276.19 | 0.0% | COM | 70975L107 |
| ZBH | Zimmer Biomet Holdings Inc | 150,000 | $13,488 | 0.5% | $94.58 | 0.0% | COM | 98956P102 |
| BMY | Bristol-Myers Squibb Co | 250,000 | $13,485 | 0.5% | $47.53 | 0.0% | COM | 110122108 |
| FULC | Fulcrum Therapeutics Inc | 950,000 | $10,745 | 0.4% | $10.18 | 0.0% | COM | 359616109 |
| — | Definium Therapeutics Inc | 637,000 | $8,529 | 0.3% | $13.39 | — | COM NEW | 60255C885 |
| DNLI | Denali Therapeutics Inc | 465,000 | $7,677 | 0.3% | $16.88 | 0.0% | COM | 24823R105 |
| TECX | Tectonic Therapeutic Inc | 328,000 | $6,842 | 0.2% | $18.58 | 0.0% | COM | 878972108 |
| MPLT | MapLight Therapeutics Inc | 385,000 | $6,763 | 0.2% | $16.75 | 0.0% | COM | 56565P103 |
| GILD | Gilead Sciences Inc | 50,000 | $6,137 | 0.2% | $120.88 | 0.0% | COM | 375558103 |
| DBVT | DBV Technologies SA | 300,000 | $5,751 | 0.2% | $19.17 | — | SPONSORED ADS | 23306J309 |
| MIRM | Mirum Pharmaceuticals Inc | 66,000 | $5,213 | 0.2% | $71.78 | 0.0% | COM | 604749101 |
| LENZ | LENZ Therapeutics Inc | 275,000 | $4,400 | 0.1% | $29.15 | 0.0% | COM | 52635N103 |
| RZLT | Rezolute Inc | 1,686,000 | $3,979 | 0.1% | $7.84 | 0.0% | COM NEW | 76200L309 |
| STRO | Sutro Biopharma Inc | 243,000 | $2,812 | 0.1% | $9.49 | 0.0% | COM SHS | 869367201 |
| GPCR | Structure Therapeutics Inc | 35,000 | $2,434 | 0.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| RGNX | REGENXBIO Inc | 34,000 | $490 | 0.0% | $12.46 | 0.0% | COM | 75901B107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | Abivax SA | 1,900,000 (+90.0%) | $256,225 (+201.8%) | 8.7% | $108.56 | — | SPONSORED ADS | 00370M103 |
| BMRN | BioMarin Pharmaceutical Inc | 3,000,000 (+261.4%) | $178,290 (+296.6%) | 6.1% | $55.48 | -1.9% | COM | 09061G101 |
| ACLX | Arcellx Inc | 2,925,000 (+134.0%) | $190,710 (+85.8%) | 6.5% | $73.32 | +8.8% | COMMON STOCK | 03940C100 |
| TSHA | Taysha Gene Therapies Inc | 13,750,000 (+150.0%) | $75,625 (+320.5%) | 2.6% | $3.90 | +24.4% | COM SHS | 877619106 |
| NRIX | Nurix Therapeutics Inc | 4,690,000 (+35.0%) | $88,969 (+177.1%) | 3.0% | $12.99 | +10.6% | COM | 67080M103 |
| ABT | Abbott Laboratories | 600,000 (+140.0%) | $75,174 (+124.5%) | 2.6% | $128.68 | -1.1% | COM | 002824100 |
| DXCM | Dexcom Inc | 1,275,000 (+96.2%) | $84,622 (+93.5%) | 2.9% | $72.03 | -10.3% | COM | 252131107 |
| ANRO | Alto Neuroscience Inc | 2,485,000 (+161.6%) | $44,233 (+1058.2%) | 1.5% | $12.14 | +3.7% | COM SHS | 02157Q109 |
| GMED | Globus Medical Inc | 1,275,000 (+2.0%) | $111,320 (+55.5%) | 3.8% | $62.94 | +20.6% | CL A | 379577208 |
| ELVN | Enliven Therapeutics Inc | 3,830,000 (+230.2%) | $58,982 (+148.4%) | 2.0% | $19.91 | +0.0% | COM | 29337E102 |
| DAWN | Day One Biopharmaceuticals Inc | 5,200,000 (+94.4%) | $48,464 (+157.0%) | 1.6% | $10.24 | -18.4% | COM | 23954D109 |
| IRON | Disc Medicine Inc | 735,000 (+47.0%) | $58,366 (+76.7%) | 2.0% | $65.10 | +29.8% | COM | 254604101 |
| APGE | Apogee Therapeutics Inc | 550,000 (+29.4%) | $41,514 (+145.9%) | 1.4% | $43.82 | +43.7% | COM | 03770N101 |
| LXEO | Lexeo Therapeutics Inc | 4,475,000 (+37.7%) | $44,437 (+105.9%) | 1.5% | $7.30 | +25.0% | COM | 52886X107 |
| KALV | KalVista Pharmaceuticals Inc | 1,890,000 (+152.0%) | $30,524 (+234.1%) | 1.0% | $12.75 | +3.8% | COM | 483497103 |
| AXSM | Axsome Therapeutics Inc | 210,000 (+40.0%) | $38,354 (+110.5%) | 1.3% | $120.35 | +16.0% | COM | 05464T104 |
| LNTH | Lantheus Holdings Inc | 360,000 (+111.8%) | $23,958 (+174.8%) | 0.8% | $63.74 | -8.7% | COM | 516544103 |
| SLDB | Solid Biosciences Inc | 5,815,000 (+95.5%) | $32,797 (+78.7%) | 1.1% | $6.44 | -15.8% | COM NEW | 83422E204 |
| ENGN | Engene Holdings Inc | 1,055,000 (+185.1%) | $9,527 (+277.0%) | 0.3% | $7.93 | +1.1% | COM | 29286M105 |
| RAPP | Rapport Therapeutics Inc | 1,110,000 (+16.8%) | $33,677 (+19.4%) | 1.1% | $19.26 | +43.7% | COM | 75383L102 |
| AGIO | Agios Pharmaceuticals Inc | 325,000 (+155.9%) | $8,847 (+73.5%) | 0.3% | $36.07 | -2.7% | COM | 00847X104 |
| MYGN | Myriad Genetics Inc | 1,223,000 (+103.8%) | $7,521 (+73.4%) | 0.3% | $6.61 | +9.8% | COM | 62855J104 |
| NVCR | Novocure Ltd | 525,000 (+31.3%) | $6,788 (+31.4%) | 0.2% | $13.24 | -3.0% | ORD SHS | G6674U108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 9,750,000 | $76,830 | 2.6% | $7.78 | +26.3% | — | 03152W109 |
| IONS | Ionis Pharmaceuticals Inc | 1,075,000 | $70,327 | 2.4% | $41.34 | +82.2% | — | 462222100 |
| BDX | Becton Dickinson & Co | 325,000 | $60,830 | 2.1% | $183.78 | +3.1% | — | 075887109 |
| DNTH | Dianthus Therapeutics Inc | 1,180,000 | $46,433 | 1.6% | $21.02 | +84.5% | — | 252828108 |
| CYTK | Cytokinetics Inc | 725,000 | $39,846 | 1.4% | $61.56 | +1.0% | — | 23282W605 |
| BIIB | Biogen Inc | 275,000 | $38,522 | 1.3% | $135.17 | +20.9% | — | 09062X103 |
| — | Cidara Therapeutics Inc | 400,000 | $38,304 | 1.3% | $21.54 | — | — | 171757206 |
| — | Astria Therapeutics Inc | 4,956,000 | $36,080 | 1.2% | $10.07 | — | — | 04635X102 |
| CRNX | Crinetics Pharmaceuticals Inc | 750,000 | $31,238 | 1.1% | $37.35 | +19.2% | — | 22663K107 |
| DHR | Danaher Corp | 150,000 | $29,739 | 1.0% | $204.57 | +7.3% | — | 235851102 |
| BLTE | Belite Bio Inc | 312,500 | $23,125 | 0.8% | $74.00 | — | — | 07782B104 |
| RARE | Ultragenyx Pharmaceutical Inc | 750,000 | $22,560 | 0.8% | $29.99 | +9.7% | — | 90400D108 |
| BRKR | Bruker Corp | 440,000 | $14,296 | 0.5% | $46.46 | -9.1% | — | 116794108 |
| REGN | Regeneron Pharmaceuticals Inc | 25,000 | $14,057 | 0.5% | $564.28 | +20.3% | — | 75886F107 |
| QURE | uniQure NV | 225,000 | $13,133 | 0.4% | $9.25 | +317.2% | — | N90064101 |
| BHVN | Biohaven Ltd | 701,700 | $10,533 | 0.4% | — | — | PUT | G1110E107 |
| INSP | Inspire Medical Systems Inc | 135,000 | $10,017 | 0.3% | $101.25 | -5.5% | — | 457730109 |
| — | Applied Therapeutics Inc | 14,250,000 | $8,620 | 0.3% | $1.06 | — | — | 03828A101 |
| CGON | CG Oncology Inc | 175,000 | $7,049 | 0.2% | $29.07 | +42.3% | — | 156944100 |
| TVRD | Tvardi Therapeutics Inc | 167,000 | $6,508 | 0.2% | $28.47 | -68.5% | — | 140755307 |
| VTYX | Ventyx Biosciences Inc | 2,050,000 | $6,376 | 0.2% | $3.49 | +113.9% | — | 92332V107 |
| GSK | GSK PLC | 125,000 | $5,395 | 0.2% | $43.16 | — | — | 37733W204 |
| EXAS | Exact Sciences Corp | 75,000 | $4,103 | 0.1% | $50.80 | +58.1% | — | 30063P105 |
| ESTA | Establishment Labs Holdings In | 100,000 | $4,099 | 0.1% | $40.85 | +47.8% | — | G31249108 |
| KOD | Kodiak Sciences Inc | 250,000 | $4,093 | 0.1% | $8.62 | +137.6% | — | 50015M109 |
| ARQT | Arcutis Biotherapeutics Inc | 200,000 | $3,770 | 0.1% | $14.94 | +71.4% | — | 03969K108 |
| RCUS | Arcus Biosciences Inc | 250,000 | $3,400 | 0.1% | $10.40 | +96.2% | — | 03969F109 |
| — | Sutro Biopharma Inc | 2,600,000 | $2,258 | 0.1% | $1.83 | — | — | 869367102 |
| LUNG | Pulmonx Corp | 830,000 | $1,345 | 0.0% | $2.09 | -10.1% | — | 745848101 |
| TRAW | Traws Pharma Inc | 150,000 | $278 | 0.0% | $5.36 | -58.5% | — | 68232V884 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | Nuvalent Inc | 46,000 (-95.8%) | $4,627 (-95.1%) | 0.2% | $86.50 | +14.0% | COM | 670703107 |
| ASND | Ascendis Pharma A/S | 175,000 (-70.8%) | $37,317 (-68.7%) | 1.3% | $180.30 | — | SPONSORED ADR | 04351P101 |
| RGEN | Repligen Corp | 83,000 (-79.3%) | $13,600 (-74.6%) | 0.5% | $121.47 | +28.9% | COM | 759916109 |
| DYN | Dyne Therapeutics Inc | 120,000 (-95.7%) | $2,347 (-93.3%) | 0.1% | $12.17 | +55.7% | COM | 26818M108 |
| SRRK | Scholar Rock Holding Corp | 700,000 (-53.3%) | $30,835 (-44.8%) | 1.0% | $37.53 | -0.1% | COM | 80706P103 |
| BCAX | Bicara Therapeutics Inc | 3,575,000 (-29.9%) | $60,167 (-25.3%) | 2.0% | $14.08 | +21.3% | COM | 055477103 |
| BDTX | Black Diamond Therapeutics Inc | 870,000 (-84.3%) | $2,114 (-89.9%) | 0.1% | $5.15 | -31.2% | COM | 09203E105 |
| XENE | Xenon Pharmaceuticals Inc | 600,000 (-45.5%) | $26,892 (-39.1%) | 0.9% | $37.23 | +12.8% | COM | 98420N105 |
| JAZZ | Jazz Pharmaceuticals PLC | 290,000 (-42.0%) | $49,300 (-25.2%) | 1.7% | $108.63 | +41.1% | SHS USD | G50871105 |
| IMTX | Immatics NV | 6,125,000 (-3.5%) | $64,313 (+18.9%) | 2.2% | $9.24 | +9.2% | SHS | N44445109 |
| GERN | Geron Corp | 11,320,000 (-34.3%) | $14,942 (-36.7%) | 0.5% | $3.11 | -59.6% | COM | 374163103 |
| ZYME | Zymeworks Inc | 865,000 (-51.0%) | $22,775 (-24.5%) | 0.8% | $12.80 | +70.4% | COM | 98985Y108 |
| GLUE | Monte Rosa Therapeutics Inc | 775,000 (-3.1%) | $12,152 (+105.0%) | 0.4% | $5.30 | +154.4% | COM | 61225M102 |
| RVMD | Revolution Medicines Inc | 295,000 (-53.2%) | $23,497 (-20.1%) | 0.8% | $38.42 | +70.7% | COM | 76155X100 |
| VERA | Vera Therapeutics Inc | 550,000 (-27.6%) | $27,852 (+26.1%) | 0.9% | $34.48 | +3.0% | CL A | 92337R101 |
| SVRA | Savara Inc | 1,606,000 (-60.0%) | $9,684 (-32.4%) | 0.3% | $4.17 | +17.3% | COM | 805111101 |
| ALEC | Alector Inc | 755,000 (-23.0%) | $1,178 (-59.4%) | 0.0% | $1.45 | +22.7% | COM | 014442107 |
| FATE | Fate Therapeutics Inc | 1,725,000 (-31.4%) | $1,695 (-46.5%) | 0.1% | $3.20 | -62.5% | COM | 31189P102 |
| CLDX | Celldex Therapeutics Inc | 1,165,000 (-3.3%) | $31,641 (+1.5%) | 1.1% | $20.34 | +29.5% | COM NEW | 15117B202 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences Inc | 2,425,000 | $63,753 | 2.2% | $14.73 | +24.7% | COM | 90240B106 |
| BBNX | Beta Bionics Inc | 600,000 | $18,282 | 0.6% | $14.44 | +84.9% | COM | 08659B102 |
| ALC | Alcon AG | 1,105,000 | $87,085 | 3.0% | $86.36 | -10.8% | ORD SHS | H01301128 |
| PASG | Passage Bio Inc | 305,000 | $3,599 | 0.1% | $6.96 | +24.0% | COM NEW | 702712209 |
| VYGR | Voyager Therapeutics Inc | 1,475,000 | $5,797 | 0.2% | $6.46 | — | COM | 92915B106 |
| TENX | Tenax Therapeutics Inc | 53,439 | $651 | 0.0% | $3.62 | +140.2% | COM NEW | 88032L605 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $1,842 | 0.1% | $15.14 | -80.2% | COM CL A | 68277Q105 |
| MGNX | MacroGenics Inc | 280,000 | $451 | 0.0% | $14.22 | -88.9% | COM | 556099109 |
| NYXH | Nyxoah SA | 1,107,000 | $5,092 | 0.2% | $8.73 | -41.1% | SHS | B6S7WD106 |